| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/12/2023 | 58.23% | Cantor Fitzgerald | $2 → $1 | Downgrades | Neutral → Underweight |
| 08/14/2023 | 97.78% | Goldman Sachs | $1.75 → $1.25 | Maintains | Sell |
| 08/10/2023 | 216.46% | Cantor Fitzgerald | $3 → $2 | Maintains | Neutral |
| 05/11/2023 | 374.68% | Cantor Fitzgerald | $4 → $3 | Maintains | Neutral |
| 04/13/2023 | 176.9% | Goldman Sachs | $2.5 → $1.75 | Maintains | Sell |
| 04/12/2023 | 176.9% | Goldman Sachs | $2.5 → $1.75 | Maintains | Sell |
| 03/07/2023 | 295.57% | Goldman Sachs | $2.5 → $2.5 | Maintains | Sell |
| 03/06/2023 | 295.57% | Goldman Sachs | $2.25 → $2.5 | Maintains | Sell |
| 03/02/2023 | 414.24% | UBS | $3.5 → $3.25 | Maintains | Neutral |
| 11/22/2022 | 532.91% | Northland Capital Markets | → $4 | Initiates Coverage On | → Outperform |
| 11/10/2022 | 256.01% | Goldman Sachs | $3 → $2.25 | Maintains | Sell |
| 08/11/2022 | 691.14% | Cantor Fitzgerald | → $5 | Downgrades | Overweight → Neutral |
| 06/21/2022 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 05/11/2022 | 374.68% | Goldman Sachs | $4 → $3 | Maintains | Sell |
| 03/10/2022 | 532.91% | Barclays | $7 → $4 | Maintains | Equal-Weight |
| 03/02/2022 | 532.91% | UBS | $4.5 → $4 | Upgrades | Sell → Neutral |
| 11/11/2021 | 1007.59% | Barclays | $12 → $7 | Downgrades | Overweight → Equal-Weight |
| 10/11/2021 | 691.14% | UBS | $14 → $5 | Downgrades | Neutral → Sell |
| 07/06/2021 | 2589.87% | Cantor Fitzgerald | → $17 | Initiates Coverage On | → Overweight |
| 03/18/2021 | 2115.19% | UBS | → $14 | Initiates Coverage On | → Neutral |
| 02/03/2021 | 1798.73% | Goldman Sachs | $19 → $12 | Downgrades | Neutral → Sell |
| 10/28/2020 | 4172.15% | JP Morgan | → $27 | Initiates Coverage On | → Neutral |
| 10/15/2020 | 3381.01% | Goldman Sachs | → $22 | Initiates Coverage On | → Neutral |
What is the target price for Hyliion Holdings (HYLN)?
The latest price target for Hyliion Holdings (NYSE: HYLN) was reported by Cantor Fitzgerald on October 12, 2023. The analyst firm set a price target for $1.00 expecting HYLN to rise to within 12 months (a possible 58.23% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Hyliion Holdings (HYLN)?
The latest analyst rating for Hyliion Holdings (NYSE: HYLN) was provided by Cantor Fitzgerald, and Hyliion Holdings downgraded their underweight rating.
When is the next analyst rating going to be posted or updated for Hyliion Holdings (HYLN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hyliion Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hyliion Holdings was filed on October 12, 2023 so you should expect the next rating to be made available sometime around October 12, 2024.
Is the Analyst Rating Hyliion Holdings (HYLN) correct?
While ratings are subjective and will change, the latest Hyliion Holdings (HYLN) rating was a downgraded with a price target of $2.00 to $1.00. The current price Hyliion Holdings (HYLN) is trading at is $0.63, which is out of the analyst's predicted range.
